Account
Inquiry
Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide/">Retatrutide is an innovative research peptide currently being studied for potential applications in obesity and metabolic disorder research. This compound represents a significant advancement in peptide research as a triple agonist that simultaneously targets three key metabolic receptors: GLP-1, GIP, and glucagon receptors.
The multi-receptor targeting mechanism of Retatrutide offers researchers a unique tool for studying complex metabolic pathways. By engaging all three receptor systems, this peptide may provide more comprehensive metabolic effects compared to single-agonist compounds.
Retatrutide is supplied as a white lyophilized powder with >99% purity as verified by HPLC analysis. The peptide is provided in research quantities suitable for laboratory studies.
This product is intended for research purposes only and is not for human consumption. All researchers should follow proper laboratory safety protocols when handling this material.
